NeuroPace (NPCE) EBIT (2020 - 2026)
NeuroPace's (NPCE) quarterly EBIT came in at -$5.6 million in Q1 2026, down 8.18% year-on-year from -$6.1 million in Q1 2025, and down 215.11% quarter-over-quarter from -$1.8 million in Q4 2025.
NeuroPace (NPCE) EBIT (2020 - 2026) Analysis & Trends
NeuroPace's EBIT history runs 7 years deep, the most recent figure standing at -$5.6 million for Q1 2026.
- On a quarterly basis, EBIT fell 8.18% year-over-year to -$5.6 million in Q1 2026; TTM through Mar 2026 was -$16.8 million, a 13.04% increase from a year earlier, with the FY2025 full-year figure at -$16.3 million, up 24.61% from the prior year.
- EBIT fell to -$5.6 million in Q1 2026 per NPCE's latest filing, from -$1.8 million in the prior quarter.
- Across five years, EBIT topped out at -$1.8 million in Q4 2025 and bottomed at -$11.0 million in Q2 2022.
- The 5-year median for EBIT is -$6.2 million (2024), against an average of -$6.6 million.
- Across the five-year window, EBIT plunged 151.99% in 2022 and soared 51.63% in 2025, its largest moves.
- Year by year, EBIT stood at -$9.9 million in 2022, then jumped by 48.77% to -$5.1 million in 2023, then advanced by 27.68% to -$3.7 million in 2024, then surged by 51.63% to -$1.8 million in 2025, then sank by 215.11% to -$5.6 million in 2026.
- Per Business Quant, the three latest NPCE EBIT figures stand at -$5.6 million (Q1 2026), -$1.8 million (Q4 2025), and -$2.6 million (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 1.35 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 936.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 1.87 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 1.10 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 477.60 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 255.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 282.15 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 515.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | NeuroPace | 494.96 Mn | 440.98 Mn | 18.05 Mn | -5.57 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5.57 Mn |
| Dec 31, 2025 | -1.77 Mn |
| Sep 30, 2025 | -2.60 Mn |
| Jun 30, 2025 | -6.82 Mn |
| Mar 31, 2025 | -5.15 Mn |
| Dec 31, 2024 | -3.65 Mn |
| Sep 30, 2024 | -4.24 Mn |
| Jun 30, 2024 | -6.23 Mn |
| Mar 31, 2024 | -7.55 Mn |
| Dec 31, 2023 | -5.05 Mn |
| Sep 30, 2023 | -5.95 Mn |
| Jun 30, 2023 | -7.85 Mn |
| Mar 31, 2023 | -8.32 Mn |
| Dec 31, 2022 | -9.86 Mn |
| Sep 30, 2022 | -10.20 Mn |
| Jun 30, 2022 | -10.97 Mn |
| Mar 31, 2022 | -9.76 Mn |
| Dec 31, 2021 | -9.02 Mn |
| Sep 30, 2021 | -6.24 Mn |
| Jun 30, 2021 | -4.61 Mn |